Imaging of Osteoradionecrosis of the Jaws

Yazarlar

Hazal Karslıoğlu
Dilek Yılmaz

Referanslar

Day TA, Davis BK, Gillespie MB, Joe JK, Kibbey M, Martin-Harris B, et al. Oral cancer treatment. Curr Treat Options Oncol. 2003;4(1): 27–41.

Brody S, Omer O, McLoughlin J, Stassen L. The dentist's role within the multi-disciplinary team maintaining quality of life for oral cancer patients in light of recent advances in radiotherapy. J Ir Dent Assoc. 2013;59(3): 137–46.

Lim AA, Karakla DW, Watkıns DV. Osteoradionecrosis of the cervical vertebrae and occipital bone: a case report and brief review of the literature. Am J Otolaryngol. 1999;20(6): 408–411.

Marx RE. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg. 1983;41: 283–288.

Teng MS, Futran ND. Osteoradionecrosis of the mandible. Curr Opin Otolaryngol Head Neck Surg. 2005;13: 217–222.

Marx RE, Johnson RP. Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol. 1987;64(4): 379–390.

Reuther T, Schuster T, Mende U, Kübler A. Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients: a report of a thirty year retrospective review. Int J Oral Maxillofac Surg. 2003;32(3): 289–295.

Epstein JB, Wong FL, Stevenson-Moore P. Osteoradionecrosis: clinical experience and a proposal for classification. J Oral Maxillofac Surg. 1987;45(2): 104–110.

Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff S. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg. 2004;62: 527–534.

Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Path Oral Radiol Endod. 2006;102(4):433-441.

Ruggiero S, Gralow J, Marx RE, et al. Practical guidelines for the prevention, diagnosis and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Pract. 2006;2: 7–14.

Freitas M, Cedrún J, Fernández J, García A, Fernández J, Diz P. Oral bisphosphonate-related osteonecrosis of the jaws: clinical characteristics of a series of 20 cases in Spain. Med Oral Patol Oral Cir Bucal. 2012;17: 751–758.

Barasch A, Cunha-Cruz J, Curro FA, et al. Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN. J Dent Res. 2011;90: 439–444.

Otto S, Abu-Id MH, Fedele S, et al. Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence: a multi-centre study. J Craniomaxillofac Surg. 2011;39: 272–277.

Morrish RB, Chan E, Silverman S, Meyer J, Fu KK, Greenspan D. Osteonecrosis in patients irradiated for head and neck carcinoma. Cancer. 1981;47(8): 1980–1983.

Thorn JJ, Hansen HS, Specht L, Bastholt L. Osteoradionecrosis of the jaws: clinical characteristics and relation to the field of irradiation. J Oral Maxillofac Surg. 2000;58(10): 1088–1093; discussion 1093–1095.

Eggert JH, Dumbach J, Steınhauser EW. Zur tiologie und Therapie der Osteoradionekrose des Unterkiefers. Dtsch Zahna¨rztl Z. 1985;40: 2–11.

Miles DA. Imaging inflammatory disorders of the jaw: simple osteitis to generalised osteomyelitis. Oral Maxillofac Surg Clin North Am. 1992;4(1): 207–221.

Niebel HH, Neeman EW. Dental aspects of osteoradionecrosis. Oral Surg Oral Med Oral Pathol. 1957;10: 1011–1024.

Epstein JB, Wong FLW, Dickens A, et al. Bone and gallium scans in postradiotherapy osteonecrosis of the jaw. Head Neck. 1992;14: 288–292.

Guttenberg SA. Osteoradionecrosis of the jaw. Am J Surg. 1974;127: 326–332.

Chong Chan K, Perschbacher S, Lam EWN, Hope AJ, Atenafu EG, Pharoah MJ. Mandibular changes on panoramic imaging after head and neck radiotherapy. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2016;121(6): 666–672.

Chronopoulos A, Zarra T, Ehrenfeld M, Otto S. Osteoradionecrosis of the jaws: definition, epidemiology, staging and clinical and radiological findings. A concise review. Int Dent J. 2018;68(1): 22–30.

Chrcanovic BR, Reher P, Sousa AA, Harris M. Osteoradionecrosis of the jaws — a current overview — part 1: physiopathology and risk and predisposing factors. Oral Maxillofac Surg. 2010;14: 3–16.

White SC, Mallya SM. Update on the biological effects of ionizing radiation, relative dose factors and radiation hygiene. Aust Dent J. 2012;57(Suppl 1): 2–8.

Beumer J, Harrison R, Sanders B, Kurrasch M. Osteoradionecrosis: predisposing factors and outcomes of therapy. Head Neck Surg. 1984;6(4): 819–827.

Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate induced exposed bone (osteonecrosisyosteopetrosis) of the jaws: risk factors, recognition, prevention and treatment. J Oral Maxillofac Surg. 2005;63: 1567–1575.

Owosho AA, Tsai CJ, Lee RS, Freymiller H, Kadempour A, Varthis S, et al. The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience. Oral Oncol. 2017;64: 44–51.

Chang DT, Sandow PR, Morris CG, Hollander R, Scarborough L, Amdur RJ, et al. Do pre-irradiation dental extractions reduce the risk of osteoradionecrosis of the mandible? Head Neck. 2007;29(6): 528–536.

Yusof ZW, Bakri MM. Severe progressive periodontal destruction due to radiation tissue injury. J Periodontol. 1993;64: 1253–1258.

Chen JA, Wang CC, Wong YK, Wang CP, Jiang RS, Lin JC, et al. Osteoradionecrosis of mandible bone in patients with oral cancer--associated factors and treatment outcomes. Head Neck. 2016;38(5): 762–758.

Ben-David MA, Diamante M, Radawski JD, Vineberg KA, Stroup C, Murdoch-Kinch CA, et al. Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions. Int J Radiat Oncol Biol Phys. 2007;68(2): 396–402.

Fujita M, Tanimoto K, Wada T. Early radiographic changes in radiation bone injury. Oral Surg Oral Med Oral Pathol. 1986;61: 641–644.

Ardran G. Bone destruction not demonstrable by radiography. Br J Radiol. 1951;24: 107–109.

Chiandussi S, Biasotto M, Dore F, Cavalli F, Cova MA, Di Lenarda R. Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws. Dentomaxillofacial Radiology. 2006;35: 236–243.

Treister NS, Friedland B, Woo SB. Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109: 753–764.

Wilde F, Heufelder M, Lorenz K, Liese S, Liese J, Helmrich J, et al. Prevalence of cone beam computed tomography imaging findings according to the clinical stage of bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114: 804–11.

Kämmerer PW, Thiem D, Eisenbeiß C, Dau M, Schulze RK, Al-Nawas B, et al. Surgical evaluation of panoramic radiography and cone beam computed tomography for therapy planning of bisphosphonate-related osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121: 419–424.

Sue M, Oda T, Sasaki Y, Ogura I. Age-related changes in the pulp chamber of maxillary and mandibular molars on cone-beam computed tomography images. Oral Radiol. 2018;34: 219–223.

Leite AF, Ogata Fdos S, de Melo NS, Figueiredo PT. Imaging findings of bisphosphonate-related osteonecrosis of the jaws: a critical review of the quantitative studies. Int J Dent. 2014;2014: 784348.

Mizuhashi F, Ogura I, Sugawara Y, Oohashi M, Sekiguchi H, Saegusa H. Characteristics of root fractures: image on intraoral radiography, panoramic radiography, and cone-beam computed tomography. Oral Sci Int. 2020;17: 34–38.

Ogura I, Minami Y, Ono J, Kanri Y, Okada Y, Igarashi K, Haga-Tsujimura M, Nakahara K, Kobayashi E. CBCT imaging and histopathological characteristics of osteoradionecrosis and medication related osteonecrosis of the jaw. Imaging Science in Dentistry. 2021;51: 73–80.

Mallya SM, Tetradis S. Imaging of radiation- and medication-related osteonecrosis. Radiol Clin North Am. 2018;56(1): 77–89.

Bachmann G, Rossler R, Klett R, et al. The role of magnetic resonance imaging and scintigraphy in the diagnosis of pathologic changes of the mandible after radiation therapy. Int J Oral Maxillofac Surg. 1996;25: 189–195.

Hermans R, Fossion E, Ioannides C, et al. CT findings in osteoradionecrosis of the mandible. Skeletal Radiol. 1996;25: 31–36.

Michaelson MD, Smith MR. Bisphosphonates for treatment and prevention of bone metastases. J Clin Oncol. 2005;23: 8219–8224.

Phal PM, Myall RW, Assael LA, et al. Imaging findings of bisphosphonate-associated osteonecrosis of the jaws. AJNR Am J Neuroradiol. 2007;28: 1139–1145.

Krishnan A, Arslanoglu A, Yildirm N, Silbergleit R, Aygun N. Imaging findings of bisphosphonate-related osteonecrosis of the jaw with emphasis on early magnetic resonance imaging findings. J Comput Assist Tomogr. 2009;33(2):298-304.

White S, Pharoah M. Oral Radiology, Principles and Interpretation. 4th ed. St. Louis: Mosby; 2000.

White, Stuart C, Michael J. Pharoah. White and Pharoah’s Oral Radiology: Principles and Interpretation. 8th ed. St. Louis: Elsevier Health Sciences; 2018. p.1068–1123.

Grisar K, Schol M, Schoenaers J, Dormaar T, Coropciuc R, Vander Poorten V, et al. Osteoradionecrosis and medication-related osteonecrosis of the jaw: similarities and differences. Int J Oral Maxillofac Surg. 2016;45(12): 1592–1599.

Gaêta-Araujo H, Vanderhaeghen O, Vasconcelos KF, Coucke W, Coropciuc R, Politis C, et al. Osteomyelitis, osteoradionecrosis, or medication-related osteonecrosis of the jaws? Can CBCT enhance radiographic diagnosis? Oral Dis. 2021;27(2): 312–319.

Bisdas S, Chambron Pinho N, Smolarz A, Sader R, Vogl TJ, Mack MG. Biphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients. Clin Radiol. 2008;63: 71–77.

Store G, Larheim TA. Mandibular osteoradionecrosis: a comparison of computed tomography with panoramic radiography. Dentomaxillofac Radiol. 1999; 28(5): 295–300.

Hamilton, D, Lai Y, Ginsberg, L. Superimposed infection in mandibular osteoradionecrosis: diagnosis and outcomes. J Comput Assist Tomogr. 2012;36(6): 725–731.

Chan KC, Perschbacher SE, Lam EW, et al. Mandibular changes on panoramic imaging after head and neck radiotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016; 121(6):666–672.

Chong J, Hinckley LK, Ginsberg LE. Masticator space abnormalities associated with mandibular osteoradionecrosis: MR and CT findings in five patients. AJNR Am J Neuroradiol. 2000; 21: 175–178.

Obinata K, Shirai S, Ito H, Nakamura M, Carrozzo M, Macleod I, Carr A, Yamazaki Y, Tei K. Image findings of bisphosphonate related osteonecrosis of jaws comparing with osteoradionecrosis. Dentomaxillofac Radiol. 2017;46(5): 20160281.

Ueno S, Gamoh S, Akiyama H, Tsuji K, Morita S. Image-based differentiation of osteomyelitis, especially between osteoradionecrosis and medication-related osteonecrosis of the jaw. J Osaka Dent Univ. 2018;52(1): 31−35.

Deshpande SS, Thakur MH, Dholam K, Mahajan A, Arya S, Juvekar S. Osteoradionecrosis of the mandible: through a radiologist’s eyes. Clinical Radiology. 2015;70: 197−205.

Paris F, Fuks Z, Kang A, et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science. 2001; 293–297.

62.Vogler JB 3rd, Murphy WA. Bone marrow imaging. Radiology. 1988;168: 679–693.

Hermans R. Imaging of mandibular osteoradionecrosis. Neuroimaging Clin N Am. 2003;13: 597–604.

Zhong X, Li L, Lu B, Zhang H, Huang L, Lin X, Li J, Zhang J. Cervical spine osteoradionecrosis or bone metastasis after radiotherapy for nasopharyngeal carcinoma? The MRI-based radiomics for characterization. BMC Medical Imaging. 2020;20: 104.

Addley HC, Vargas HA, Moyle PL, Crawford R, Sala E. Pelvic imaging following chemotherapy and radiation therapy for gynecologic malignancies. Radiographics. 2010;30: 1843–1856.

Alexander JM. Radionuclide bone scanning in the diagnosis of lesions of the maxillofacial region. J Oral Surg. 1976;34: 249–256.

Ohira H, Kubota K, Ohuchi N, et al. Comparison of intratumoral distribution of 99mTc-Mibi and deoxyglucose in mouse breast cancer models. J Nucl Med. 2000;41: 1561–1568.

Fleisher KE, Raad RA, Rakheja R, Gupta V, Chan KC, Friedman KP, Mourtzikos KA, Janal M, Glickman RS. Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw. J Oral Maxillofac Surg. 2014;72: 1957–1965.

Akashi M, Wanifuchi S, Kusumoto J, Kishimoto M, Kakei Y, Hashikawa K, Komori T. Potential role of post-treatment follow-up FDG-PET CT to detect mandibular osteoradionecrosis: A case report. Mol Clin Oncol. 2018; 8(1): 61–67.

Hakim SG, Bruecker CW, H Ch Jacobsen, Hermes D, Lauer I, Eckerle S, Froehlich A, Sieg P. The value of FDG-PET and bone scintigraphy with SPECT in the primary diagnosis and follow-up of patients with chronic osteomyelitis of the mandible. Int J Oral Maxillofac Surg. 2006;35: 809–816. Available from:

Minn H, Aitasalo K, Happonen RP. Detection of cancer recurrence in irradiated mandible using positron emission tomography. Eur Arch Otorhinolaryngol. 1993;250: 312–315.

Alhilali L, Reynolds AR, Fakhran S. Osteoradionecrosis after radiation therapy for head and neck cancer: differentiation from recurrent disease with CT and PET/CT imaging. AJNR Am J Neuroradiol. 2014; 35(7): 1405–1411.

Sayfalar

43-60

Gelecek

8 Kasım 2023

Lisans

Lisans